Pelion's activities

As President of the PGF Management Board, Ms Magdalena Tomaszewska will focus on further strengthening the company's position on the demanding and competitive healthcare market, and on effective implementation of a coherent and long-term growth strategy. Ms Tomaszewska will seek to ensure that the PGF brand is consistently synonymous with reliable and secure pharmaceutical distribution as well as the highest quality and comprehensive nature of the services provided to pharmacies and patients in Poland. She will work closely with all stakeholders on the Polish pharmaceutical market, i.e. pharmacies, manufacturers as well as industry and social organizations, in compliance with PGF’s overriding principles of trust and operational transparency.

Magdalena Tomaszewska graduated from the Faculty of Pharmacy of the Medical Academy in Warsaw, and completed an MBA programme at the International School of Management in Warsaw. Since the beginning of her career, Ms Tomaszewska has been associated with the pharmaceutical industry. She worked for the world's largest manufacturers, including Pfizer, Novartis, J&J and Ratiopharm. In 2010, she joined Glenmark Pharmaceuticals, where in recent years she served as President for Europe, Russia, South America and Asia, based in Prague and London.

Ms Tomaszewska comes with long-standing international experience in strategic and operational management in the pharmaceutical industry, and specializes in the optimization of business processes and resources, communication, and building cooperation networks.

The vast knowledge and experience of Ms Magdalena Tomaszewska, acquired at reputable pharmaceutical companies in Poland and abroad, will undoubtedly contribute to the achievement of the ambitious goals set for Polska Grupa Farmaceutyczna. These competencies, coupled with Magdalena's pharmaceutical education, are of great importance for the understanding of pharmacies’ needs in the context of their current environment in Poland, for providing services of the highest quality, and for the joint efforts to support Polish patients, said Jacek Szwajcowski, Pelion’s CEO.

Polska Grupa Farmaceutyczna is one of the most advanced and largest drug distributors in Central Europe.  It works with nearly 700 suppliers and over 10 thousand pharmacies, and offers almost 19 thousand stock keeping units. Every day a million packages of medicines leave the company's storage facilities all over Poland, so that – in line with the PGF mission – “patients could always get the necessary medicines". Founded in 1990, the company is owned by Pelion S.A.

Twenty-seven years of knowledge and experience, a well-established market position, skilled employees, as well as modern and centrally managed logistics and storage infrastructure which meets the stringent requirements of Good Distribution Practices – all these elements constitute a strong and stable foundation for PGF’s responsible development and ability to fulfill its mission, which is to ensure full availability of medicines for patients, to support the work of the Partners and Clients, and to actively participate in the shaping of the modern health care system in Poland.